Like many others, I am pleased to have been offered the option of "new treatments for covid-19" in the event that I test positive. I agree with one respondent to another post on this subject who commented that it makes sense to consider the option before one tests positive, rather than having to make a potentially tricky decision "in the heat of the moment". In that vein I have been giving it some thought and would welcome the views of others.
The problem, as I see it, is that the efficacy of Sotrovimab (assuming that is the drug we would be offered?) depends on the speed with which one takes the medication after contracting the virus. Clearly, at that point one does not know if without the drug, the virus would have a mild or serious impact. One might think that, regardless of this unknown factor, it is worth taking the drug "just in case". However, I feel that as this is a new and relatively untested drug, the potential side effects should be taken into account. In the GSK factsheet on the drug these are listed as follows:
"What are the important possible side effects of sotrovimab?
Possible side effects of sotrovimab are:
• Allergic reactions. Allergic reactions can happen during and after infusion with sotrovimab. Tell your
healthcare provider right away if you get any of the following signs and symptoms of allergic
reactions: fever; difficulty breathing; low oxygen level in your blood; chills; tiredness; fast or slow heart
rate; chest discomfort or pain; weakness; confusion; nausea; headache; shortness of breath; low or
high blood pressure; wheezing; swelling of your lips, face, or throat; rash including hives; itching;
muscle aches; dizziness; feeling faint; and sweating.
The side effects of getting any medicine through a vein may include brief pain, bleeding, bruising of the
skin, soreness, swelling, and possible infection at the infusion site.
These are not all the possible side effects of sotrovimab. Not many people have been given sotrovimab.
Serious and unexpected side effects may happen. Sotrovimab is still being studied, so it is possible that
all of the risks are not known at this time.
It is possible that sotrovimab could interfere with your body’s own ability to fight off a future infection of
SARS-CoV-2. Similarly, sotrovimab may reduce your body’s immune response to a vaccine for SARS-
CoV-2. Specific studies have not been conducted to address these possible risks."
Some of this sounds less than ideal to me, and I think that if I were to pay for one of those antibody test kits, and I found that my antibody level was "good", would I want to risk the potential side effects of the drug when the likely effect of the virus was mild?
Am I missing something here? Maybe, because I've been on pred for several years, the liklihood is that the virus would have a serious effect on me. Presumably this is the logic behind the email.
I just feel that the broadbrushed approach that has been taken to sending out the email is not very nuanced.
Thoughts please.